MYOF and neoplasm: The absence of a link between cancer cell myoferlin abundance with patient survival was very surprising to us, as previous studies demonstrated that myoferlin ablation in tumor cells impaired tumor size (Gupta et al, 2021; Rademaker et al, 2022).